Recently, the pharmaceutical excipient betadex sulfobutyl ether sodium produced by Anhui Poly Pharm. Co., Ltd (Anhui Poly), a holding subsidiary of Hainan Poly Pharm. Co., Ltd (Poly Pharm), was approved in the joint review with drug products on the API, Excipient, and Packaging Material Platform of China’s NMPA Center for Drug Evaluation (CDE). This means that the product passed the associated review and was approved for use in marketed drug products. The product is stable and available for customers worldwide.
A few days ago, Poly Pharm contributed the quality specifications of the API gadoterate meglumine to The United States Pharmacopeial Convention (USP). Dr. Guoshan Cen, General Manager of USP China, paid a visit to Poly Pharm with his team and awarded the enterprise a certificate of appreciation as well as a trophy.
Anhui Poly Pharm Co., Ltd (hereinafter referred to as “Anhui Poly”), a wholly owned subsidiary of Hainan Poly Pharm Co., Ltd (hereinafter referred to as “Hainan Poly”), is delivering the orders of the API gadobutrol to Turkey these days.
Good News: Recently, according to the relevant requirements of “Interim Measures for Gradient Cultivation and Management of Green Factories (GXBJ [2024] No. 13)”, and “Interim Measures for Evaluation and Management of Green Factories in Anhui Province (WJXJN [2019] No. 98)”, the Anhui Provincial Department of Industry and Information Technology organized and carried out the 2024 Anhui Province Green Factory Evaluation. Through enterprise application, municipal recommendation, expert review, meeting review, and public announcement, 150 enterprises including NIO Automotive Technology (Anhui) Co., Ltd. were identified as Anhui Green Factories (2024), and the list was released as follows:
Anhui Poly Pharm. Co., Ltd. (hereinafter referred to as "Anhui Poly"), a subsidiary of Hainan Poly Pharm. Co., Ltd. (hereinafter referred to as "Poly Pharm."), has recently received the certificate of suitability for the European Pharmacopoeia (CEP) for the pharmaceutical excipient Betadex Sulfobutyl Ether Sodium issued by European Director for the Quality of Medicine&HealthCare (hereinafter referred to as "EDQM")
